Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitra Tsavachidou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Medical Informatics Association : JAMIA|September 12, 2002
Modeling and simulation of pathways in menopauseDimitra Tsavachidou, Michael N Liebman
Cancer Research|August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutantDimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Proteome Science|September 26, 2012
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arraysHuifang Guo, Wenbin Liu, Zhenlin Ju, et al.
Cancer Immunology Research|April 30, 2014
CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapyHong Chen, Tihui Fu, Woong-Kyung Suh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in boneEleni Efstathiou, Mark Titus, Dimitra Tsavachidou, et al.
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinomaJinhee Kim, Eric Jonasch, Angela Alexander, et al.
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Medical Informatics Association : JAMIA|September 12, 2002
Modeling and simulation of pathways in menopauseDimitra Tsavachidou, Michael N Liebman
Cancer Research|August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutantDimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Proteome Science|September 26, 2012
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arraysHuifang Guo, Wenbin Liu, Zhenlin Ju, et al.
Cancer Immunology Research|April 30, 2014
CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapyHong Chen, Tihui Fu, Woong-Kyung Suh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in boneEleni Efstathiou, Mark Titus, Dimitra Tsavachidou, et al.
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinomaJinhee Kim, Eric Jonasch, Angela Alexander, et al.
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Pageof 1